WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, laid out medtech’s vital role in the Trump administration’s “Make America Healthy Again” initiative, calling for policies that ensure faster, broader access to lifesaving medtech.
Whitaker wrote, “As the Trump administration works to ‘Make America Healthy Again,’ medtech has been and continues to be a proven part of the solution. Our industry looks forward to working with the administration to achieve our shared goal of making sure America is as healthy as it can possibly be.”
The op-ed highlights the wide range of medtech innovations that are transforming patient care, from wearable medtech that monitors chronic conditions and delivers real-time AI analytics, to AI-powered diagnostic imaging tools, to surgical robots enabling minimally invasive procedures that help deliver better outcomes and decrease costs.
“Name any condition, and you will find medtech scientists and engineers developing a solution for it all over the U.S. to save and improve lives,” Whitaker wrote.
Read the full op-ed here. Read more about medtech’s role in improving Americans’ health here.